Prenatal diagnosis of HSP

Posted - March 2007 in Research Highlights

Direct foetal gene analysis of the most prevalent form of HSP has been successfully performed.

This is the first report on direct prenatal diagnosis of chromosome 2p-linked AD-HSP (SPG4). In addition, we report a novel SPG4-combined small insertion/deletion mutation in exon 5, which may be the first SPG4 mutational hot spot.

OBJECTIVE: To present a report on prenatal diagnosis using direct SPG4 gene analysis in a family with autosomal dominant hereditary spastic paraplegia (AD-HSP).

METHODS: Genetic linkage and haplotype analysis were previously carried out with chromosome 2p markers. DNA was obtained from affected individuals, the affected father, the mother, and fetal DNA from an ongoing pregnancy by chorionic villus sampling (CVS) in the first trimester. The spastin gene (SPG4) was completely sequenced.

RESULTS: A novel 832insGdelAA frameshift mutation, predicted to cause loss of functional protein, was identified in the affected father and in the fetal DNA.

Copyright 2004 John Wiley & Sons, Ltd.

Prenat Diagn. 2004 May;24(5):363-6.

Prenatal diagnosis of autosomal dominant hereditary spastic paraplegia (SPG4) using direct mutation detection.

Nielsen JE, Koefoed P, Kjaergaard S, Jensen LN, Norremolle A, Hasholt L.

Institute of Medical Biochemistry and Genetics, Department of Medical Genetics, Section of Neurogenetics, University of Copenhagen, The Panum Institute, Copenhagen, Denmark. [email protected]